Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AunaFRA:GZ4 +2.70%44 EV-to-EBIT is 9.17 as of Sep. 05, 2026, which is 4% above its 10-year median of 8.84. GuruFocus rates FRA:GZ4 with a GF Score™ of 44/100. The stock has 5 warning signs investors should review. Among 477 Healthcare Providers & Services companies, Auna ranks better than 75.89% on this metric.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Auna's Enterprise Value is €1,201 Mil.
Auna's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was €131 Mil. Therefore, Auna's EV-to-EBIT for today is 9.17.
The historical rank and industry rank for Auna's EV-to-EBIT or its related term are showing as below:
FRA:GZ4'
s EV-to-EBIT Range Over the Past 10 Years
Min: 6.68 Med: 8.84 Max: 15.88
Current: 9.2
During the past 9 years, the highest EV-to-EBIT of Auna was 15.88. The lowest was 6.68. And the median was 8.84.
FRA:GZ4's EV-to-EBIT is ranked better than 75.89% of 477
companies
in the Healthcare Providers & Services industry
Industry Median: 15.52
vs FRA:GZ4: 9.20
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Auna's Enterprise Value for the quarter that ended in Jun. 2026 was €1,205 Mil.
Auna's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €131 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Auna EV-to-EBIT Related Terms
Auna EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Auna's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Auna's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Auna EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Auna's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Auna's EV-to-EBIT falls into.
Auna's current Enterprise Value is €1,201 Mil.
Auna's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €131 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Auna (FRA:GZ4) has a EV-to-EBIT of 9.17 as of Sep. 05, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Auna and its competitors. This is near median its historical median of 8.84. Over the past decade, Auna's EV-to-EBIT has ranged from 6.68 to 15.88. According to the industry distribution chart, Auna ranks #115 out of 477 companies in the Healthcare Providers & Services industry, placing it in the top 24.1%.
Is Auna's EV-to-EBIT too high?
Auna's current EV-to-EBIT of 9.17 is near median its 10-year median of 8.84. Over the past 10 years, this metric has ranged from a low of 6.68 to a high of 15.88. The Healthcare Providers & Services industry median EV-to-EBIT is 15.52. Auna's value of 9.17 is 40.9% below this industry median. Based on the distribution chart, Auna ranks #115 out of 477 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Auna has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Auna's EV-to-EBIT compare to CYH and SRTA?
According to the Healthcare Providers & Services industry distribution chart, Auna ranks #115 out of 477 companies for EV-to-EBIT. This places Auna in the top 24% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 15.52. Auna's value of 9.17 is 40.9% below this benchmark. Historically, Auna's own EV-to-EBIT has ranged from 6.68 to 15.88 over the past decade. While the company's 10-year median is 8.84 vs. the industry median of 15.52, Auna has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.52, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Auna's current EV-to-EBIT of 9.17 is 40.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Auna and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Auna's current EV-to-EBIT is 9.17, which is near median its own 10-year median of 8.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Auna stock overvalued right now?
Auna (FRA:GZ4) has a current EV-to-EBIT of 9.17. The current EV-to-EBIT is 9.17, which is near median its 10-year median of 8.84 and 40.9% below the Healthcare Providers & Services industry median of 15.52. Auna's overall GF Score™ is 44/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Auna (FRA:GZ4), the current EV-to-EBIT is 9.17 as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Auna SA is a healthcare provider. It operates hospitals and clinics in Mexico, Peru, and Colombia, and provides prepaid healthcare plans in Peru and dental and vision plans in Mexico. Its network includes several healthcare network facilities, consisting of hospitals, outpatient, prevention, and wellness facilities. The company operates in the following segments: Oncosalud Peru and Healthcare services in Peru, Colombia, and Mexico. Geographically, operates in Peru, Colombia, and Mexico, with the maximium of revenue from Peru.
44GF Score
Get the complete analysis for FRA:GZ4
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:GZ4 has been successfully added to your 
